Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.22.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]        
Revenues $ 79,374 $ 47,210 $ 193,827 $ 174,193
Operating expenses        
Cost of product sold 88,105 110,465 212,979 340,161
Selling, general and administrative expense 469,659 398,964 1,292,913 832,293
Total operating expenses 557,764 509,429 1,505,892 1,172,454
Loss from operations (478,390) (462,219) (1,312,065) (998,261)
Interest expense – bank debt 338 675
Interest expense - shareholder 4,909 125,575 4,909 209,530
Interest expense – financing cost 270,210   270,210  
Amortization of debt discount 12,218 254,048 12,218 576,787
(Gain)/loss on extinguishment of debt upon notes conversion (186,181) 2,216
Change in derivative liability (57,294) (264,818)
Other expense- non cash 15,192 15,192 19,877
Total other expense 302,529 136,486 302,529 544,267
Provision for income tax
Net Loss (780,919) (598,705) (1,614,594) (1,542,528)
Deemed dividend on Series B Stock 68,722 358,657
Net loss attributable to common shareholders $ (849,641) $ (598,705) $ (1,973,251) $ (1,542,528)
Basic and diluted net loss per common share (in Dollars per share) $ (0.01) $ (0.01) $ (0.02) $ (0.03)
Weighted average shares of capital outstanding – basic and diluted (in Shares) 86,407,410 66,744,545 84,400,978 65,093,781